Condition
CNS Infection
Total Trials
5
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Unknown4
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07358117Active Not Recruiting
Viral Infections of the Central Nervous System: Diagnosis and Clinical Outcome
NCT04775784Unknown
Determination of COVID-19 Related Virus in Central Nervous System
NCT03786497Unknown
Protecting Brains and Saving Futures - the PBSF Protocol
NCT04141787Phase 4Unknown
Ceftriaxone as Home IV for Staph Infections
NCT03715569UnknownPrimary
CNS Infections Effect on the Inner Ear
Showing all 5 trials